SEWELL NINA VINCENT 4
4 · CORAUTUS GENETICS INC · Filed Oct 15, 2003
Insider Transaction Report
Form 4
SEWELL NINA VINCENT
Sr VP - Clinical & Regulatory
Transactions
- Award
Stock Option (right to buy)
2003-10-13+50,000→ 50,000 totalExercise: $4.78From: 2003-10-13Exp: 2013-10-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Stock options vest according to the following schedule: (i) 10,000 upon commencement of treatment of 202nd patient in Issuer's Phase II(b) clinical trial; (ii) 10,000 upon commencement of treatment of 404th patient in Issuer's Phase II(b) clinicial trial; (iii) all remaining unvested options on October 13, 2005.